1. Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients
- Author
-
S. Samiei, H. C. van Beek, T. J. A. van Nijnatten, A. J. G. Maaskant-Braat, Marjolein L. Smidt, Robert-Jan Schipper, Marc B. I. Lobbes, S.M.J. van Kuijk, M. P. J. Polak, Esther M. Heuts, Promovendi ODB, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: DA BV AIOS Radiologie (9), Surgery, MUMC+: MA Heelkunde (9), MUMC+: KIO Kemta (9), Epidemiologie, RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: MA AIOS Heelkunde (9), Beeldvorming, and MUMC+: DA BV Medisch Specialisten Radiologie (9)
- Subjects
MULTICENTER ,lcsh:Medicine ,PREOPERATIVE ULTRASONOGRAPHY ,Surgical planning ,030218 nuclear medicine & medical imaging ,0302 clinical medicine ,Surgical oncology ,Breast MRI ,lcsh:Science ,DISSECTION ,Lymph node ,Ultrasonography ,Observer Variation ,Multidisciplinary ,medicine.diagnostic_test ,Middle Aged ,Magnetic Resonance Imaging ,medicine.anatomical_structure ,Outcomes research ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,BIOPSY ,Radiographic Image Interpretation, Computer-Assisted ,Female ,Lymph ,Radiology ,SENTINEL-NODE ,Adult ,medicine.medical_specialty ,Breast Neoplasms ,Sensitivity and Specificity ,Article ,Diagnosis, Differential ,03 medical and health sciences ,Breast cancer ,medicine ,Humans ,RECONSTRUCTION ,Aged ,FINE-NEEDLE-ASPIRATION ,LYMPH-NODES ,business.industry ,lcsh:R ,Axillary Lymph Node Dissection ,medicine.disease ,FDG-PET/CT ,METASTASIS ,Axilla ,Lymph Node Excision ,lcsh:Q ,Histopathology ,business - Abstract
Preoperative differentiation between limited (pN1; 1–3 axillary metastases) and advanced (pN2–3; ≥4 axillary metastases) nodal disease can provide relevant information regarding surgical planning and guiding adjuvant radiation therapy. The aim was to evaluate the diagnostic performance of preoperative axillary ultrasound (US) and breast MRI for differentiation between pN1 and pN2–3 in clinically node-positive breast cancer. A total of 49 patients were included with axillary metastasis confirmed by US-guided tissue sampling. All had undergone breast MRI between 2008–2014 and subsequent axillary lymph node dissection. Unenhanced T2-weighted MRI exams were reviewed by two radiologists independently. Each lymph node on the MRI exams was scored using a confidence scale (0–4) and compared with histopathology. Diagnostic performance parameters were calculated for differentiation between pN1 and pN2–3. Interobserver agreement was determined using Cohen’s kappa coefficient. At final histopathology, 67.3% (33/49) and 32.7% (16/49) of patients were pN1 and pN2–3, respectively. Breast MRI was comparable to US in terms of accuracy (MRI reader 1 vs US, 71.4% vs 69.4%, p = 0.99; MRI reader 2 vs US, 73.5% vs 69.4%, p = 0.77). In the case of 1–3 suspicious lymph nodes, pN2–3 was observed in 30.4% on US (positive predictive value (PPV) 69.6%) and in 22.2–24.3% on MRI (PPV 75.7–77.8%). In the case of ≥4 suspicious lymph nodes, pN1 was observed in 33.3% on US (negative predictive value (NPV) 66.7%) and in 38.5–41.7% on MRI (NPV 58.3–61.5%). Interobserver agreement was considered good (k = 0.73). In clinically node-positive patients, the diagnostic performance of axillary US and breast MRI is comparable and limited for accurate differentiation between pN1 and pN2–3. Therefore, there seems no added clinical value of preoperative breast MRI regarding nodal staging in patients with positive axillary US.
- Published
- 2019